PROLIXIN ENANTHATE Drug Patent Profile
✉ Email this page to a colleague
When do Prolixin Enanthate patents expire, and what generic alternatives are available?
Prolixin Enanthate is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in PROLIXIN ENANTHATE is fluphenazine enanthate. There are nineteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROLIXIN ENANTHATE?
- What are the global sales for PROLIXIN ENANTHATE?
- What is Average Wholesale Price for PROLIXIN ENANTHATE?
Summary for PROLIXIN ENANTHATE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Patent Applications: | 834 |
| DailyMed Link: | PROLIXIN ENANTHATE at DailyMed |
US Patents and Regulatory Information for PROLIXIN ENANTHATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apothecon | PROLIXIN ENANTHATE | fluphenazine enanthate | INJECTABLE;INJECTION | 016110-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
